Designed specifically for use with the Atellica CH Analyzer, the Atellica CH Glucose Oxidase (GluO) assay facilitates accurate, in vitro quantitative determination of glucose levels in human serum, cerebrospinal fluid (CSF), plasma (lithium heparin), and urine.
This essential diagnostic tool assists healthcare professionals in diagnosing and managing carbohydrate metabolism disorders such as diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia, and cases of insulin overdose.
Optimized for efficiency, the reagent supports up to 5,600 tests, offering laboratories high throughput capabilities and reliability.
